交易 Synaptogenix, Inc. - SNPX CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
价差 | - | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.024068% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.001846% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
---|
Synaptogenix, Inc. Events
時間(協調世界時) (UTC) | 國家 | 事件 |
---|---|---|
No events scheduled |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
总收入 | 0 | 0 | 0 | 0 |
总营业费用 | 12.6183 | 12.8564 | 15.5135 | 11.1494 |
销售/一般/行政费用,总计 | 8.28189 | 8.08738 | 10.9725 | 6.26383 |
研究与开发 | 4.33641 | 3.06903 | 4.54095 | 4.88556 |
营业收入 | -12.6183 | -12.8564 | -15.5135 | -11.1494 |
利息收入(费用),非经营净值 | 0.00711 | 0.15321 | 0.37871 | 0.12711 |
税前净收入 | -12.6112 | -12.7032 | -15.1348 | -11.0223 |
税后净收入 | -12.6112 | -12.7032 | -15.1348 | -11.0223 |
未计算非常项目前的净收益 | -12.6112 | -12.7032 | -15.1348 | -11.0223 |
净收入 | -12.6112 | -12.7032 | -15.1348 | -11.0223 |
普通股股东可获收益 (不含非经常性项目) | -12.6112 | -15.1302 | -15.1348 | -11.0223 |
普通股股东可获收益 (含非經常性項目) | -12.6112 | -15.1302 | -15.1348 | -11.0223 |
摊薄净收入 | -12.6112 | -15.1302 | -15.1348 | -11.0223 |
摊薄后加权平均股 | 5.0151 | 1.25758 | 1.32211 | 1.32211 |
扣除特别项目的每股摊薄盈利 | -2.51465 | -12.0312 | -11.4474 | -8.33687 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | |
每股正常摊薄盈利 | -2.51465 | -10.6794 | -11.4474 | -8.33687 |
异常费用(收入) | 0 | 1.7 | ||
Total Adjustments to Net Income | -2.427 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
总收入 | 0 | 0 | 0 | 0 | 0 |
总营业费用 | 3.28253 | 4.23856 | 2.92938 | 2.29517 | 3.15519 |
销售/一般/行政费用,总计 | 1.79646 | 2.87693 | 2.09266 | 1.30889 | 2.00341 |
研究与开发 | 1.48607 | 1.36164 | 0.83672 | 0.98628 | 1.15178 |
营业收入 | -3.28253 | -4.23856 | -2.92938 | -2.29517 | -3.15519 |
利息收入(费用),非经营净值 | 0.00461 | 0.00252 | 0.00245 | 0.00133 | 0.00082 |
税前净收入 | -3.27792 | -4.23605 | -2.92693 | -2.29384 | -3.15438 |
税后净收入 | -3.27792 | -4.23605 | -2.92693 | -2.29384 | -3.15438 |
未计算非常项目前的净收益 | -3.27792 | -4.23605 | -2.92693 | -2.29384 | -3.15438 |
净收入 | -3.27792 | -4.23605 | -2.92693 | -2.29384 | -3.15438 |
普通股股东可获收益 (不含非经常性项目) | -3.27792 | -4.23605 | -2.92693 | -2.29384 | -3.15438 |
普通股股东可获收益 (含非經常性項目) | -3.27792 | -4.23605 | -2.92693 | -2.29384 | -3.15438 |
摊薄净收入 | -3.27792 | -4.23605 | -2.92693 | -2.29384 | -3.15438 |
摊薄后加权平均股 | 6.9392 | 6.7998 | 6.1966 | 3.9712 | 2.96903 |
扣除特别项目的每股摊薄盈利 | -0.47238 | -0.62297 | -0.47234 | -0.57762 | -1.06243 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.47238 | -0.62297 | -0.47234 | -0.57762 | -1.06243 |
异常费用(收入) | 0 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
流动资产总额 | 35.5042 | 6.72879 | 17.8762 | 29.4575 |
现金和短期投资 | 34.214 | 5.79506 | 17.382 | 28.8542 |
现金等价物 | 34.214 | 5.79506 | 17.382 | 28.8542 |
Prepaid Expenses | 1.29023 | 0.80629 | 0.49411 | 0.60332 |
Total Assets | 35.5247 | 6.751 | 17.8978 | 29.4784 |
Property/Plant/Equipment, Total - Net | 0.02045 | 0.02221 | 0.02167 | 0.02084 |
Total Current Liabilities | 1.99491 | 1.61249 | 0.47906 | 2.95708 |
Accounts Payable | 1.29651 | 1.26034 | 0.41308 | 2.89858 |
Accrued Expenses | 0.69841 | 0.35215 | 0.06598 | 0.05849 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 |
Total Liabilities | 1.99491 | 1.61249 | 0.47906 | 2.95708 |
Total Long Term Debt | 0 | 0 | 0 | 0 |
Total Equity | 33.5298 | 5.13851 | 17.4188 | 26.5213 |
Common Stock | 0.00067 | 0.0005 | 0.00131 | 0.00129 |
Additional Paid-In Capital | 47.6707 | 6.66848 | 106.234 | 100.202 |
Retained Earnings (Accumulated Deficit) | -14.1417 | -1.53047 | -88.8168 | -73.6821 |
Total Liabilities & Shareholders’ Equity | 35.5247 | 6.751 | 17.8978 | 29.4784 |
Total Common Shares Outstanding | 6.73018 | 1.25758 | 1.32211 | 1.32211 |
应收账款总额,净额 | 0.12745 | |||
Other Equity, Total | 0 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流动资产总额 | 32.3342 | 35.5042 | 32.3402 | 32.9402 | 16.3257 |
现金和短期投资 | 31.2817 | 34.214 | 31.2946 | 31.7021 | 14.8484 |
现金等价物 | 31.2817 | 34.214 | 31.2946 | 31.7021 | 14.8484 |
应收账款总额,净额 | 0 | 0 | |||
Prepaid Expenses | 1.05247 | 1.29023 | 1.04551 | 1.23816 | 1.47723 |
Total Assets | 32.3533 | 35.5247 | 32.3586 | 32.96 | 16.3466 |
Property/Plant/Equipment, Total - Net | 0.01913 | 0.02045 | 0.01849 | 0.01973 | 0.02097 |
Total Current Liabilities | 0.66934 | 1.99491 | 1.00733 | 0.76997 | 0.93744 |
Accounts Payable | 0.40135 | 1.29651 | 0.93538 | 0.64816 | 0.75896 |
Accrued Expenses | 0.26799 | 0.69841 | 0.07195 | 0.12181 | 0.17848 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 0.66934 | 1.99491 | 1.00733 | 0.76997 | 0.93744 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 31.684 | 33.5298 | 31.3513 | 32.19 | 15.4092 |
Common Stock | 0.00068 | 0.00067 | 0.00062 | 0.0006 | 0.0014 |
Additional Paid-In Capital | 49.1029 | 47.6707 | 41.2563 | 39.1681 | 20.0927 |
Retained Earnings (Accumulated Deficit) | -17.4196 | -14.1417 | -9.90563 | -6.97869 | -4.68485 |
Total Liabilities & Shareholders’ Equity | 32.3533 | 35.5247 | 32.3586 | 32.96 | 16.3466 |
Total Common Shares Outstanding | 6.80965 | 6.73018 | 6.13697 | 6.0388 | 3.50813 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
净收入/起跑线 | -12.6112 | -12.7032 | -15.1348 | -11.0223 |
经营活动产生的现金 | -8.71073 | -8.1024 | -11.8868 | -7.69677 |
经营活动产生的现金 | 0.00497 | 0.00487 | 0.00439 | 0.003 |
非现金物品 | 3.86958 | 3.90212 | 5.61236 | 2.21661 |
营运资金的变化 | 0.02593 | 0.69381 | -2.36881 | 1.10591 |
投资活动产生的现金 | -0.0032 | -0.00541 | -0.00521 | -0.00319 |
资本支出 | -0.0032 | -0.00541 | -0.00521 | -0.00319 |
融资活动产生的现金 | 37.1329 | -3.47917 | 0.41984 | 20.441 |
股票的发行(报废),净额 | 37.1344 | 16.5242 | 0.41984 | 20.441 |
现金净变化 | 28.4189 | -11.587 | -11.4722 | 12.7411 |
融资现金流项目 | -0.00153 | -20.0034 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -3.27792 | -12.6112 | -8.37515 | -5.44822 | -3.15438 |
Cash From Operating Activities | -3.48541 | -8.71073 | -6.66556 | -5.58532 | -3.58672 |
Cash From Operating Activities | 0.00132 | 0.00497 | 0.00373 | 0.00249 | 0.00125 |
Non-Cash Items | 0.87901 | 3.86958 | 2.4228 | 1.1348 | 0.91241 |
Changes in Working Capital | -1.08781 | 0.02593 | -0.71694 | -1.27439 | -1.34599 |
Cash From Investing Activities | -0.0032 | 0 | 0 | 0 | |
Capital Expenditures | -0.0032 | 0 | 0 | 0 | |
Cash From Financing Activities | 0.55315 | 37.1329 | 32.1651 | 31.4923 | 12.6401 |
Financing Cash Flow Items | 0 | -0.00153 | -0.00153 | 0.12592 | 0.12745 |
Issuance (Retirement) of Stock, Net | 0.55315 | 37.1344 | 32.1667 | 31.3664 | 12.5127 |
Net Change in Cash | -2.93226 | 28.4189 | 25.4996 | 25.907 | 9.0534 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
Alpha Capital Aktiengesellschaft | Holding Company | 4.1055 | 301977 | -29305 | 2021-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.0271 | 222654 | 159 | 2022-12-31 | LOW |
Intracoastal Capital, L.L.C. | Corporation | 2.4304 | 178765 | 178365 | 2022-12-31 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8472 | 62316 | -159 | 2022-12-31 | LOW |
Perry (George) | Individual Investor | 0.5438 | 40000 | 40000 | 2021-07-13 | |
Silverman (Joshua) | Individual Investor | 0.5199 | 38238 | 33238 | 2022-12-20 | LOW |
Alkon (Daniel L M.D.) | Individual Investor | 0.4833 | 35547 | 34062 | 2022-12-20 | |
Citadel Advisors LLC | Hedge Fund | 0.4655 | 34238 | 34238 | 2022-12-31 | HIGH |
Weinstein (Robert) | Individual Investor | 0.4513 | 33198 | 33000 | 2022-12-20 | HIGH |
Singer (William S) | Individual Investor | 0.4487 | 33000 | 33000 | 2022-12-20 | HIGH |
Tuchman (Alan J) | Individual Investor | 0.4487 | 33000 | 33000 | 2022-12-20 | LOW |
Cannell & Co. | Investment Advisor | 0.4079 | 30000 | -46220 | 2022-12-31 | LOW |
Bernstein (Bruce T.) | Individual Investor | 0.3749 | 27578 | 27500 | 2022-12-20 | LOW |
Schechter (Jonathan L) | Individual Investor | 0.3705 | 27250 | 24750 | 2022-12-20 | HIGH |
Diametric Capital | Investment Advisor/Hedge Fund | 0.3609 | 26549 | -1172 | 2022-09-30 | HIGH |
Platform Technology Partners LLC | Investment Advisor | 0.3418 | 25138 | 9106 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2733 | 20100 | 0 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.2065 | 15188 | 348 | 2022-12-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.1835 | 13500 | -3000 | 2022-12-31 | HIGH |
Advisor Group, Inc | Investment Advisor | 0.1244 | 9148 | 8600 | 2022-12-31 | LOW |
交易計算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
貿易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
開倉
平倉
做空 做多
Synaptogenix, Inc. Company profile
关于 Synaptogenix Inc
Synaptogenix公司,前身为Neurotrope生物科学公司,是一家生物制药公司。 该公司主要致力于为神经退行性疾病和发育障碍患者开发治疗方法。 公司正在开发一个基于候选药物Bryostatin-1的产品平台,该药物是由一种从海洋无脊椎生物中分离出来的天然产品(ryostatin)合成的,用于治疗阿尔茨海默病(AD)。 其主要候选产品是 Bryostatin-1。 Bryostatin-1是一种蛋白激酶C Epsilon(PKC e),是一种和e激活剂,最初被开发为潜在的抗癌药物。 该公司还在评估 Bryostatin在其他神经退行性或认知性疾病和功能障碍方面的治疗应用,如脆性X综合征、多发性硬化症和Niemann-Pick C型疾病,这些都已进行了临床前测试。
Industry: | Biotechnology & Medical Research (NEC) |
1185 Avenue Of The Americas, 3Rd Floor
NEW YORK
NEW YORK 10036
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。